RecombiPure

RecombiPure is a biotechnology company and a portfolio company of Ichor Life Sciences that specializes in protein engineering and recombinant protein expression. The company's proprietary RecombiPure platform enables the production of full-length, properly folded, and biologically active proteins that are typically difficult to synthesize, such as human p53, at scale in E. coli. This technology is a critical component of Ichor's vertically integrated drug discovery pipeline, supporting high-throughput screening for age-related disease targets. RecombiPure also developed RPtag, a hyper-stable antibody mimetic scaffold based on a ribose-binding protein from extremophiles, which serves as a versatile tool for protein purification and a potential therapeutic delivery platform.